Matteo Simonelli Selected Research

Matteo Simonelli Research Topics

Disease

31	Neoplasms (Cancer) 03/2024 - 01/2007
18	Glioma (Gliomas) 03/2024 - 02/2007
18	Glioblastoma (Glioblastoma Multiforme) 02/2024 - 02/2007
5	Malignant Mesothelioma 10/2017 - 04/2009
4	Brain Neoplasms (Brain Tumor) 12/2023 - 09/2010
4	Thymoma (Thymic Carcinoma) 01/2018 - 03/2009
3	Melanoma (Melanoma, Malignant) 01/2024 - 02/2015
3	Infertility (Sterility) 05/2021 - 11/2016
3	Disease Progression 08/2020 - 01/2018
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 06/2011
2	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2006
2	Pneumonia (Pneumonitis) 01/2021 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 02/2015 - 02/2013
1	Epilepsy (Aura) 01/2024
1	Lung Neoplasms (Lung Cancer) 12/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021
1	Ependymoma 12/2021
1	Sarcopenia 06/2021
1	Residual Neoplasm 05/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021
1	Lung Injury 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	COVID-19 01/2021
1	Oligodendroglioma 12/2020
1	Turcot syndrome 09/2020
1	Primary Ovarian Insufficiency 12/2019
1	Amenorrhea 12/2019
1	Lymphatic Metastasis 12/2019
1	Angiosarcoma of the breast 12/2019
1	Meningioma (Meningiomas) 05/2012
1	Mesothelioma 04/2011
1	Thymus Neoplasms (Thymus Neoplasm) 10/2010

Drug/Important Bio-Agent (IBA)

9	Temozolomide (Temodar)FDA LinkGeneric 05/2022 - 02/2007
5	Immune Checkpoint InhibitorsIBA 12/2021 - 12/2016
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2017
4	Proteins (Proteins, Gene)FDA Link 09/2020 - 10/2010
3	Methionine (L-Methionine)FDA Link 01/2024 - 09/2010
3	Pemetrexed (MTA)FDA Link 10/2017 - 04/2011
3	Sorafenib (BAY 43-9006)FDA Link 02/2015 - 03/2013
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2024 - 02/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2020
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 01/2018
2	pembrolizumabIBA 01/2021 - 08/2020
2	PlatinumIBA 01/2018 - 04/2011
2	ARQ 197IBA 02/2015 - 02/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015 - 03/2013
2	Lapatinib (GW572016)FDA Link 01/2015 - 03/2013
1	vorasidenibIBA 01/2024
1	cemiplimabIBA 01/2024
1	Serum AlbuminIBA 01/2024
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2024
1	O-(6)-methylguanineIBA 05/2022
1	MethyltransferasesIBA 05/2022
1	ribociclibIBA 01/2022
1	ceritinibIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	SteroidsIBA 01/2022
1	LY3300054IBA 12/2021
1	130-nm albumin-bound paclitaxelIBA 12/2021
1	Antineoplastic Agents (Antineoplastics)IBA 12/2021
1	Gemcitabine FDA Link 12/2021
1	depatuxizumab mafodotinIBA 06/2021
1	monooxyethylene trimethylolpropane tristearate (MTTS)IBA 05/2021
1	LigandsIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Circulating Tumor DNAIBA 02/2020
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 01/2020
1	Ifosfamide FDA LinkGeneric 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019
1	pazopanib FDA Link 12/2019
1	Everolimus FDA Link 01/2018
1	NivolumabIBA 12/2016
1	Monoclonal AntibodiesIBA 12/2016
1	ErbB Receptors (EGF Receptor)IBA 03/2013
1	Sunitinib (Sutent)FDA Link 06/2011
1	Carboplatin (JM8)FDA LinkGeneric 04/2011
1	Thymidylate SynthaseIBA 04/2011
1	Messenger RNA (mRNA)IBA 04/2011
1	Serine (L-Serine)FDA Link 10/2010
1	Insulin (Novolin)FDA Link 10/2010
1	Amino Acids FDA Link 09/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010
1	asparagine-glycine-arginineIBA 05/2010

Therapy/Procedure

16	Therapeutics 03/2024 - 01/2007
15	Drug Therapy (Chemotherapy) 05/2022 - 01/2006
13	Radiotherapy 01/2022 - 02/2007
7	Immunotherapy 01/2024 - 09/2018
3	Adjuvant Chemotherapy 03/2024 - 01/2006
1	Chemoradiotherapy 05/2022
1	Re-Irradiation 01/2022
1	Investigational Therapies (Experimental Therapy) 01/2021
1	Adjuvant Radiotherapy 09/2020
1	Molecular Targeted Therapy 12/2019
1	Salvage Therapy 01/2018
1	Operative Surgical Procedures 05/2012
1	Retreatment 04/2011